Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
11.83
+0.10 (0.90%)
Apr 30, 2025, 4:00 PM EDT - Market closed
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $1.34 billion as of April 30, 2025. Its market cap has decreased by -38.71% in one year.
Market Cap
1.34B
Enterprise Value
719.19M
1-Year Change
-38.71%
Ranking
Category
Stock Price
$11.83
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $1.34B, an increase of 69.90%. That is a compound annual growth rate of 12.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2025 | 1.34B | -44.12% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 802.66B |
| Johnson & Johnson | 374.79B |
| UnitedHealth Group | 374.10B |
| AbbVie | 340.09B |
| Novo Nordisk | 287.71B |
| Abbott Laboratories | 225.03B |
| Novartis AG | 224.16B |
| AstraZeneca | 220.68B |